EU and AstraZeneca Claim Dispute Results



UMMATIMES - Both the European Union and AstraZeneca on Friday (18/6) claimed victory in a court dispute over the delivery of a Covid-19 vaccine.

The European Union (EU) and AstraZeneca have been at loggerheads since AstraZeneca first announced it was delaying its shipments to the 27-nation bloc in January 2021.

The European Commission said the judge acknowledged that AstraZeneca had committed a serious breach of its contractual obligations in terms of the supply of the Covid-19 vaccine.

European Commission President Ursula von der Leyen welcomed the decision. He said the decision confirmed the position of the European Commission that AstraZeneca did not fulfill the commitments made in the contract. "It is good to see that an independent judge confirmed this." said von der Leyen.

But in its own statement, AstraZeneca said it welcomed the decision and that the court had rejected the European Commission's request for the company to supply a total of 300 million doses by the end of September 2021.

"To date, the Company has supplied more than 70 million doses to the European Union and will substantially exceed 80.2 million doses by the end of June 2021. All other measures requested by the European Commission have been rejected, and in particular the Court finds that the European Commission does not have exclusivity or priority rights over all parties," AstraZeneca explained.

AstraZeneca also said the ruling recognized that the difficulties AstraZeneca was experiencing in this unprecedented situation had a major impact on the delay.

AstraZeneca's General Adviser, Jeffrey Pott, said AstraZeneca has fully complied with its agreement with the EU.

"We will continue to focus on the urgent task of supplying an effective vaccine, which we are delivering at no profit to help protect people in Europe and around the world from the deadliest pandemic in a generation," said Pott.